1
0
0
(1 - 15 von 17
)
Incretin-based medications (GLP-1 receptor agonists, DPP- ...ScienceDirect
www.sciencedirect.com
von J Farngren · · Zitiert von: 13 — ... from the Incretin Hormones and Incretin-based Glucose-lowering Medications Special Issue, Edited by Michael Nauck, Manfredi Rizzo and Christos Mantzoros.
Michael A. Nauck and David A. D'Alessio - BMC blog networkblogs.biomedcentral.com › blog › author › nauckda...
blogs.biomedcentral.com
· Professor Michael Nauck is Head of Clinical Research, Diabetes, at the St. Josef Hospital, Ruhr-University Bochum, and has studied the ...
Gesundheitsbezogene Lebensqualität bei Personen mit ...
fis.uni-bamberg.de
von D Gorges · · Zitiert von: 2 — ... Diabetes-Gesellschaft ; Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, Mai Tagungspräsident: Michael Nauck, p. › handle › uniba
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared...
www.sciencedirect.com
... from the Incretin Hormones and Incretin-based Glucose-lowering Medications Special Issue, Edited by Michael Nauck, Manfredi Rizzo and Christos Mantzoros.
Coronavirus research collection - Cardiovascular Diabetology
cardiab.biomedcentral.com
... Nebojša Lalić, Michael Lehrke, Nikolaus Marx, Michael Nauck, Helena W. Rodbard, Giuseppe M. C. Rosano, Peter Rossing, Lars Rydén, Francesca Santilli, ... › ...
Nüchtern - C - Peptid und daraus abgeleitete Parameter zur ...
ediss.uni-goettingen.de
von FS Becht · — Doctoral thesis. Date of Examination: Date of issue: Advisor:Prof. Dr. Michael Nauck. Referee:Prof. Dr. Dirk Raddatz. Referee:Prof. › ha...
Will medications that mimic gut hormones or target their ...
www.sciencedirect.com
von A Kokkinos · · Zitiert von: 19 — ... from the Incretin Hormones and Incretin-based Glucose-lowering Medications Special Issue, Edited by Michael Nauck, Manfredi Rizzo and Christos Mantzoros. › pii
Report from the 5th cardiovascular outcome trial (CVOT) summit
cardiab.biomedcentral.com
von O Schnell · · Zitiert von: 15 — Michael Nauck. Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, Via Milanese 300Sesto San Giovanni (MI), ... › ...
Untersuchungen zur Definition der klinischen Diagnose...
ediss.uni-goettingen.de
Gutachter: Nauck, Michael Prof. Dr. Gutachter: Raddatz, Dirk Prof. Dr. Zum Verlinken/Zitieren: http://hdl.handle.net F-E8CB
Special Issues - Metabolism - Journal - Elsevier
www.sciencedirect.com
Metabolism promotes excellence in research by publishing high-quality original research papers, fast-tracking cutting-edge papers, research brief reports, min…
Welche Faktoren beeinflussen die Zufriedenheit mit der...
fis.uni-bamberg.de
... Tagungsmotto "Diabetestherapie in Bewegung" - www.ddg2010.de, Stuttgart, Mai Tagungspräsident: Michael Nauck (2010), p.
Molecular Metabolism Editorial Board - Elsevierwww.journals.elsevier.com › molecular-metabolism
www.sciencedirect.com
Michael Nauck. Ruhr University Bochum, Bochum, Germany. Stephen O'Rahilly. University of Cambridge School of Clinical Medicine, Cambridge, United ...
Prävalenz von Hypoglykämieproblemen bei insulinbehandelten Typ
fis.uni-bamberg.de
Mai Tagungspräsident: Michael Nauck, S Auch als Veröff. im Internet : https://www.thieme-connect.de/ejournals/toc/ds grouping
Metabolism | Incretin Hormones and Incretin-based Glucose-lowering...
www.sciencedirect.com
· Incretin Hormones and Incretin-based Glucose-lowering Medications. Edited by Michael Nauck, Manfredi Rizzo, Christos Mantzoros ...
Head-to-head trial of two diabetes drugs yields mixed results
www.sciencedaily.com
Daily injections of liraglutide were slightly more effective than weekly injections of exenatide in lowering blood sugar and promoting weight loss. However,...
Verwandte Suchanfragen zu Michael Nauck
Georg Brabant Gabriele Fehm-Wolfsdorf Marc Schlamann |
Person "Nauck" (1) Vorname "Michael" (149265) Name "Nauck" (124) |
sortiert nach Relevanz / Datum